VBI Vaccines, Inc. (VBIV) Financials

VBIV Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 100.8 million 80.9 million
2023-06-30 88.3 million 79.6 million
2023-03-31 128.5 million 83.4 million
2022-12-31 155.1 million 90.9 million

VBIV Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.1 million 1.5 million
2023-06-30 -19.3 million 1.7 million
2023-03-31 -22.2 million 2.0 million
2022-12-31 -20.5 million 2.3 million

VBIV Net Income

No data available :(

VBIV Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 35.5 million - 2.4 million
2023-06-30 20.8 million 47.8 million 2.7 million
2023-03-31 40.4 million - 3.0 million
2022-12-31 62.6 million 48.9 million 3.3 million

VBIV Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 21.2 million
2023-06-30 8.6 million
2023-03-31 8.6 million
2022-12-31 8.6 million

VBIV Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 113000 1.5 million 9.0 million -
2023-06-30 50000 3.3 million 10.9 million -
2023-03-31 534000 3.2 million 13.3 million -
2022-12-31 1.5 million 2.5 million 15.9 million -

VBIV Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 6.6 million 2.5 million
2023-06-30 720000 3.5 million
2023-03-31 485000 3.6 million
2022-12-31 293000 3.3 million

VBIV

Price: $0.57

52 week price:
0.45
5.70

Earnings Per Share: -9.79 USD

P/E Ratio: -0.07

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 314214

Ebitda: -32.9 million

Market Capitalization: 16.8 million

Average Dividend Frequency: 1

Links: